Stock Evaluator: Davion Healthcare Plc (DAVI)
Davion Healthcare Plc DAVI
$1.68
-1.01
-37.55%
October 30, 2026 4:00:00 PM
EST
Volume: 1,354,764
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.
Financial Summary
| Share Statistics | DAVI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $67.3 | $425.5 | 19% |
|
| Shares Out (Mil) | 29.4 | 40.4 | 37% |
|
| Institutional Ownership | na | 83.0% | na |
|
| Float (Mil) | na | 34.7 | na |
|
| Beta | na | 0.85 | na |
|
| Avg Daily Volume (000s) | 3,344 | 287 | 88% |
|
| Price Change (52-week) |
na | 65.2% | na |
|
| Growth | DAVI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.5%) | na |
|
| EPS (5yr) | na | 10.7% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | DAVI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $128 | na |
|
| Net Income (TTM) (Mil) | ($1) | ($9) | 37% |
|
| EPS (TTM) | ($0.039) | ($0.400) | 37% |
|
| Operating Cash Flow (TTM) (Mil) | $0 | ($2) | 32% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $23 | 18% |
|
| Enterprise Value (Q1) (Mil) | $88 | $399 | 20% |
|
| Valuation | DAVI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.89 | 2.49 | 21% |
|
| P/E | na | 28.5 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | DAVI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.3% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (1.3%) | (11.8%) | 35% |
|
| ROE | (1.4%) | (10.1%) | 34% |
|
| Liabilities to Assets | 1.5% | 47.2% | 0% |
|
| F-Score | na | 4 | % |
|
Davion Healthcare Plc did not pass any screens on 10/29/2026.
